For the Inventor, By the Inventor

Enter assignee name

British Biotech Pharmaceuticals Limited

USPTO Granted Patents = 85

Forward Citations = 426

Loading Chart...

Loading Chart...

56 inventors (with patents filed for the assignee):

Mark Whittaker (44 out of 53 patents)

Raymond Paul Beckett (34 out of 38 patents)

Andrew Miller (26 out of 32 patents)

4. Fionna Mitchell Martin (15 out of 15 patents)

5. Zoe Marie Spavold (14 out of 15 patents)

6. Michael George Hunter (13 out of 17 patents)

7. John Martin Clements (10 out of 10 patents)

8. Lisa Marie Pratt (9 out of 9 patents)

9. Michael John Crimmin (9 out of 14 patents)

10. Andrew Paul Ayscough (8 out of 8 patents)

11. Stephen Arthur Bowles (8 out of 12 patents)

12. Steven Launchbury (7 out of 7 patents)

13. Richard Mark Edwards (7 out of 11 patents)

14. Christopher David Floyd (7 out of 7 patents)

15. Christopher Norman Lewis (6 out of 8 patents)

Core Competencies:

Hydroxamic Acid Derivatives

Antibacterial Agents

Cytostatic Agents

Metalloproteinase Inhibitors

Anti-Inflammatory Agents

Stem Cell Inhibiting Proteins

Chimeric Virus-Like Particles

Synthesis of Carboxylic Acid Derivatives

Inflammatory Cell Inhibitors

Dioxolane Intermediates

Modified Plasmin Precursors

Disaggregated Mutant Human RANTES

85 patents: Sort by Forward Citations

1. 7323563 - Hydroxamic acid derivatives as antibacterials (2008-01-29),

2. 7323448 - Antibacterial agents (2008-01-29),

3. 7186719 - Antibacterial agents (2007-03-06),

4. 7173053 - N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infections (2007-02-06),

5. 7148198 - Antibacterial agents (2006-12-12),

6. 6992190 - Hydroxamic acid derivatives as antibacterials (2006-01-31),

7. 6908911 - Antibacterial agents (2005-06-21),

8. 6846825 - Antibacterial agents (2005-01-25),

9. 6790834 - Cytostatic agents (2004-09-14),

10. 6787522 - Antibacterial agents (2004-09-07),

11. 6545051 - Antibacterial hydroxamic acid derivatives (2003-04-08),

12. 6503897 - Antibacterial agents (2003-01-07),

13. 6495597 - Cytostatic agents (2002-12-17),

14. 6479502 - Hydroxamic acid derivatives as proteinase inhibitors (2002-11-12),

15. 6462023 - Cytostatic agents (2002-10-08),

British Biotech Pharmaceuticals Limited is a leading pharmaceutical company specializing in the research, development, and marketing of innovative healthcare products. With a dedicated team of scientists and professionals, we strive to improve patient outcomes and address unmet medical needs. Our portfolio includes a wide range of drugs across various therapeutic areas, including oncology, cardiology, neurology, and infectious diseases. We are committed to scientific excellence, regulatory compliance, and ethical practices, driving our mission to make a positive impact on global healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

85 Patents

#10 in

#205 in United Kingdom

#8,656 in the World

British Biotech Pharmaceuticals Limited

Forward Citations = 426

56 inventors:

Mark Whittaker (44 out of 53 patents)

Raymond Paul Beckett (34 out of 38 patents)

Andrew Miller (26 out of 32 patents)

4. Fionna Mitchell Martin (15 out of 15 patents)

5. Zoe Marie Spavold (14 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…